China Approves Merck’s Molnupiravir for Emergency Use, Regulator Says
admin China’s top drug regulator said Friday that it approved Merck & Co.’s Molnupiravir for emergency…
Read MoreNew Products/Services
FTC sues to block Microsoft’s $69 billion acquisition of game giant Activision Blizzard
The Federal Trade Commission on Thursday sued Microsoft Corp. to block its $69 billion deal…
Read MoreBioVie Shares jump Premarket on Parkinson’s, Alzheimer’s Studies >BIVI
By Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading Tuesday after the…
Read MoreRoche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of…
Read MoreAMD launches 18 models of new Epyc data-center chip at a time when it might be ‘more important than ever’
Advanced Micro Devices Corp. showed off Thursday how it plans to keep embedded and data-center…
Read MoreGSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients…
Read MoreTwitter reportedly delays rollout of new blue-checkmark system until after midterm elections
Twitter Inc. will delay its launch of its new blue-checkmark system until after the midterm…
Read MoreDisney overtook Netflix as the streaming leader, and is expected to widen the lead
Walt Disney Co. displaced Netflix Inc. as king of the video-streaming market, and it is…
Read MoreTwitter launches new $8 subscriptions for verification, days before U.S. midterm elections
Twitter Inc. has started giving users who sign up for $8 a month a verified…
Read MoreWarner Bros. Discovery to speed up merger of HBO Max, Discovery+
Warner Bros. Discovery Inc. is speeding up the launch of a combined HBO Max/Discovery+ streaming…
Read More